The Board expects that underlying revenue and profit from the Group, enhanced by the acquisition of Belgian business, Floren & Cie, in February 2019, will be in line with market expectations. The Group has experienced strong cash performance in the second half of the year which has resulted in net debt as at 31 December 2019 being better than market expectations.
Back to All News
All Market News
Other Market News
Caledonia – Public Companies Spotlight
Bunzl – Trading Update
AstraZeneca Release Datroway Update
J.P.Morgan European Growth & Income – Final Results
Primary Health Properties – Combination Recommendation
GSK Release Arexvy Update
Sign up for our Stock News Highlights
Delivered to your inbox every Friday